Post-orgasmic illness syndrome is a rare condition that causes extreme exhaustion and muscle pain after ejaculation. A newly ...

New research published in The Journal of Clinical Investigation argues that Alzheimer’s may begin much earlier than ...

This review argues that women’s higher Alzheimer disease risk may be shaped in part by midlife neuroendocrine aging, ...

First and only FDA-approved therapy for the treatment of acquired hypothalamic obesity, a rare disease characterized by accelerated and ...

A new study finds menopause, especially the drop in estrogen, may trigger early Alzheimer’s-related brain changes in women.

Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the ...

(NYSE: PFE) today announced positive topline results from the Phase 3 TALAPRO-3 study of TALZENNA ® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI ® ...

New York, March 16, 2026 (GLOBE NEWSWIRE) -- NEW YORK (March 16, 2026) -- The Brain & Behavior Research Foundation (BBRF) today announced it will award $1 million in Distinguished Investigator Grants ...

First and only FDA-approved therapy for the treatment of acquired hypothalamic obesity, a rare disease characterized by accelerated and sustained weight gain caused by hypothalamic injury or dysfuncti ...

Four substudies did not meet pre-specified primary endpoints -- -- Post hoc analyses show setmelanotide achieved statistically significant BMI reductions in patients with obesity due to a heterozygous ...

Pancreatic cancer remains one of the deadliest of the major cancers, with a five-year survival rate of only 13%. It’s a ...

The dominant paradigm of metabolic treatment has long operated within a narrow frame: reduce caloric intake, increase caloric expenditure, manage the consequences. That framework is now obsolete. The ...